IEEE Brain: Abbott Neuromodulation - The Importance and Practice of Late-stage Innovation

38 views
Download
  • Share

Erika Ross, Ph.D.
Director, Applied Research | Abbott Neuromodulation
Erika is the Director of Applied Research at Abbott Neuromodulation, leading
applied research strategy, external partnerships, portfolio, and execution. Applied
research includes computational modeling, pre-clinical, feasibility, and clinical
safety trials that feed new products and indications.Prior to her role at Abbott, Erika
was the Neuroscience Director at Cala Health, a Stanford Biodesign incubated start-up
that has been developing a non-invasive, digitally enabled neuromodulation solution for Essential Tremor
patients. She has held roles of increasing leadership at Cala Health as the company completed
development and prepared for commercialization. Prior to Cala Health, Erika held the roles of Assistant
Professor of Neurologic Surgery and Deputy Director of the Surgical Device Innovation Accelerator at the
Mayo Clinic in Rochester, Minn.
Kyle

Abbott Neuromodulation: The Importance and Practice of Late-stage Innovation

Advertisment

Advertisment